Page 7 - Nyse Taro News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nyse taro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nyse Taro Today - Breaking & Trending Today
Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Rating) shares gapped up before the market opened on Friday . The stock had previously closed at $25.29, but opened at $26.13. Taro Pharmaceutical Industries shares last traded at $26.13, with a volume of 276 shares trading hands. Wall Street Analyst Weigh In A number of equities research […] ....
Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday. Separately, HC Wainwright cut their price objective on Taro Pharmaceutical Industries from $54.00 to $35.00 and set a “buy” rating on the […] ....
Shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Rating) saw unusually-strong trading volume on Monday . Approximately 9,107 shares changed hands during mid-day trading, a decline of 34% from the previous session’s volume of 13,853 shares.The stock last traded at $24.89 and had previously closed at $24.33. Wall Street Analyst Weigh In TARO has […] ....
Inspire Advisors LLC raised its position in Taro Pharmaceutical Industries Ltd. (NYSE:TARO – Get Rating) by 13.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,815 shares of the company’s stock after acquiring an additional 913 shares during the quarter. Inspire Advisors LLC’s holdings […] ....
StockNews.com lowered shares of Taro Pharmaceutical Industries (NYSE:TARO – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Saturday. Separately, HC Wainwright lowered their price objective on Taro Pharmaceutical Industries from $54.00 to $35.00 and set a buy rating for the company in a research report […] ....